Biodesix Inc Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 24.55M45.56M54.51M38.21M49.09M71.32M
Cost of Revenue 6.07M22.00M30.52M14.15M13.01M15.57M
Gross Profit 18.48M23.56M23.99M24.06M36.08M55.75M
Operating items
Research & Development 10.47M10.82M12.79M13.10M9.99M9.56M
Selling, General & Administrative 30.64M34.86M50.52M61.46M67.39M80.45M
Other Operating Expenses 10.19M22.82M32.14M14.23M13.05M15.81M
Operating Expenses 51.29M68.49M95.45M88.80M90.43M105.82M
Operating Income -26.74M-22.93M-40.94M-50.59M-41.34M-34.50M
EBIT -26.74M-22.93M-40.94M-50.59M-41.34M-34.50M
Non-operating items
Interest & Investment Income 0.06M0.02M
Other Non Operating Income -3.98M-8.42M2.30M-14.86M0.01M-0.25M
Non Operating Income -3.98M-8.42M-2.22M-14.86M-10.80M-8.43M
Net income details
EBT -29.69M-30.52M-45.45M-58.66M-50.88M-42.76M
Profit After Tax -30.73M-31.35M-43.16M-65.45M-52.15M-42.93M
Income from Continuing Operations -29.69M-30.52M-45.45M-58.66M-50.88M-42.76M
Consolidated Net Income -29.69M-30.52M-45.45M-58.66M-50.88M-42.76M
Income towards Parent Company -29.69M-30.52M-45.45M-58.66M-50.88M-42.76M
Net Income towards Common Stockholders -29.69M-30.52M-45.45M-58.66M-50.88M-42.76M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.32M1.33M1.57M2.10M4.52M7.27M
Shares Outstanding (Diluted Average) 27.36M42.10M82.11M129.67M
EBITDA -26.74M-22.93M-40.94M-50.59M-41.34M-34.50M